MARION ALEXANDER: Open Payments
NPI 1235609629 · ELKIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 57 payments from 21 companies in 2025. Trend: 2023 $980 · 2024 $1,293 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $395 |
| Otsuka America Pharmaceutical, Inc. | 7 | $154 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $61 |
| PFIZER INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ABBVIE INC. | 2 | $31 |
| Eisai Inc. | 2 | $30 |
| Exact Sciences Corporation | 2 | $30 |
| Abbott Laboratories | 1 | $26 |
Products named: Wegovy, REXULTI, FARXIGA, CAPLYTA, TRELEGY ELLIPTA, VRAYLAR, Leqembi, Cologuard Collection Kit.
Industry payments across NC — which companies pay providers there.
